COVID-19 Overview
During the COVID 19 pandemic the KEMRI-Wellcome has leveraged on its existing expertise in conducting internationally acclaimed research on emerging causes of disease and mortality to provide the evidence to improve health. We work closely with the Kenyan Ministry of health, regional and international partnering institutions, with the aim of providing timely and responsive evidence …
- Testing: We are a primary testing facility for COVID-19 samples in the coastal region in Kenya
- Genome Sequencing: We are conducting genetic sequencing work to track transmission of COVID-19 cases
- Therapeutics trials: We are conducting a trial on prophylactic therapy for COVID-19
News
30
May
Consultative workshop to discuss the use of research surveillance data for decision-making.
KEMRI – Wellcome Trust hosted stakeholders and researchers for a consultative workshop to discuss the use of research surveillance data for decision-making. The workshop included a case study on integrating routine and research data, presentation of a Research Surveillance Data Dashboard and a panel discussion on data use for health.
Read more
16
Mar
UK High Commissioner’s Visit
We hosted Her Excellency, Jane Marriot, UK High Commissioner in Kenya. The visit provided an opportunity for our researchers to share their experiences using their research expertise in responding to emerging health issues.
Read more
24
Nov
Media Visit
We hosted local and international media who visited the Programme to cover the programme’s response to the COVID-19 pandemic and the beginning of the ChAdOx1 nCoV -19 vaccine trial.
Read more
02
Nov
Start of the ChAdOx1 nCoV-19 trials in Kenya
Kenya has joined the global efforts in search of an effective vaccine for COVID-19 with the start of a trial evaluating a leading COVID-19 vaccine candidate ChAdOx1 nCoV-19.
Read more
Publications & Resources
Do you have COVID-19 Symptoms?
Visit the nearest health center to get tested.
Media & Gallery
FAQs
